Sema Yılmaz Rakıcı

14PUBLICATIONS

24CO-AUTHORS

Instruments and techniquesPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 13, 2026

Clinical Impact of PSMA PET Fusion-Based RT Planning on Dosimetry and PSA Response in Prostate Cancer.

|Feb 24, 2026

Response to letter regarding: "sarcopenia is a bad harbinger of cancer-related survival in rectal cancer".

Sema Yilmaz Rakici

|Dec 19, 2025

Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer.

Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi

|Nov 27, 2025

Could Different Doses of Dexmedetomidine Be as Effective as Amifostine Against Radiotherapy-Induced Liver Injury in Rats? Evidence from Mitotic, Apoptotic, Oxidative, and Neurogenic Insights.

Hatice Beyazal Polat, Hamit Yilmaz, Kasım Demir

|Oct 29, 2025

Dexmedetomidine as a Protective Agent Against X-Ray Ionizing Radiation-Induced Small Intestinal Injury.

Süleyman Kalcan, Levent Tumkaya, Tolga Mercantepe

|Sep 27, 2025

A Dose-Dependent Study Examining Dexmedetomidine's Possible Effects Against Oxidative, Fibrotic, and Apoptotic Damage Induced by Radiation Exposure in Spleen Tissue.

Hatice Beyazal Polat, Hamit Yılmaz, Kagan Kilinc

Pageof 3

Frequent Collaborators

Tolga Mercantepe

Levent Tumkaya

Hamit Yılmaz

Filiz Mercantepe

Sibel Mataraci Karakas

Sibel Göksel

Kagan Kilinc

Levent Tumkaya

Belemir Gülhan

Serkan Akın

Frequent Collaborators

Tolga Mercantepe

Levent Tumkaya

Hamit Yılmaz

Filiz Mercantepe